OTC - ACTIVE INGREDIENT SECTION
glycerin
glycerin
water, betaine, carbomer, arginine, sodium hyaluronate, malt ext, cetyl alcohol, stearic acid, etc
sun block, skin protectant
keep out of reach of the children
apply proper amount to the skin
・Stop using the product when you have skin problems or the
product disagrees with your skin
・Stop using the product immediately and
consult a dermatologist if you have redness, swelling, itching or
irritation on the skin while or after using the product.
・If the
product gets into the eyes, don't rub but rinse with water.
・Don't
place the product in any place where it will be subjected to extremely
high or low temperatures or direct sunlight.
for external use only
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d1c9d1af-bddd-448d-86f7-69052b7d5b47 | Product name | 1 | 20220627 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 1681bc73-b05f-12c3-1075-382ae39f449c | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69346-5001-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0987-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69346-5001-1 | WELLAGE WRINKLE REDUCED VIALS | 7 mL in 1 VIAL | CONCENTRATE | 7 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69346-5001 | WELLAGE WRINKLE REDUCED VIALS (GLYCERIN) CONCENTRATE [HUGEL PHARMA CO.,LTD] | 1 | Legacy NDC, 1 package rows | 20150122_ccaf188c-3019-49e9-948c-b68b6d4ef378.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| GLYCERIN | ACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERIN | ACTIVE MOIETY | PDC6A3C0OX | 1 | |
| ARGININE | INACTIVE INGREDIENT | 94ZLA3W45F | 1 | |
| BETAINE | INACTIVE INGREDIENT | 3SCV180C9W | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69346-5001 | 69346-5001-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GLYCERIN | PDC6A3C0OX | ACTIB |
| WATER | 059QF0KO0R | IACT |
| BETAINE | 3SCV180C9W | IACT |
| ARGININE | 94ZLA3W45F | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ARGININE | ARGININE | 94ZLA3W45F | TABLET, FILM COATED / ORAL | 25 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | TABLET, EXTENDED RELEASE / ORAL | 20 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION, SOLUTION / INTRAVENOUS | 0.29 %w/v | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 6240 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | TABLET / ORAL | 50 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | POWDER, FOR SOLUTION / INTRAVENOUS | 7.07 %w/v | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 6240 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | ADJ PH | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION / INTRAMUSCULAR | NA | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 3600 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION / INTRAVENOUS | 790 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c8a48abf-a453-4f70-a5fd-808c38cf20a8 | ccaf188c-3019-49e9-948c-b68b6d4ef378 | 2015-01-22 | Warnings | c8a48abf-a453-4f70-a5fd-808c38cf20a8 ccaf188c-3019-49e9-948c-b68b6d4ef378 |
Adverse event summaries are temporarily unavailable. Other product information remains available.